An2 Therapeutics (ANTX)'s 30-day implied volatility (IV30) was 99.6% at the close on November 12, 2026, down from 102.6% the day before, against a 52-week range of 60.7% to 106.7%. Its 20-day historical volatility was 104.3%.
Data as of November 12, 2026.